Potential molecular targets for manipulating the radiation response

被引:102
作者
Maity, A
Kao, GD
Muschel, RJ
McKenna, WG
机构
[1] UNIV PENN,SCH MED,DEPT RADIAT ONCOL & PATHOL,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,DEPT LAB MED,PHILADELPHIA,PA 19104
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 37卷 / 03期
关键词
DNA damage and repair; gene induction; signal transduction; apoptosis; p53; cell-cycle checkpoints; cyclins;
D O I
10.1016/S0360-3016(96)00598-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent advances in our understanding of the molecular events that occur following ionizing radiation leading to DNA damage and repair, apoptosis, and cell-cycle arrests suggest new ways in which the radiation response might be manipulated. Specific targets which, if inactivated, might increase radiosensitivity include Ras, which has been implicated in the radioresistant phenotype, and components of DNA-dependent protein kinase or other molecules involved in the recognition or repair of DNA damage. In some tumors, apoptosis is an important mode of cell death following radiation, so agents that promote this may prove useful therapeutically. Conversely, side effects may result from radiation-induced apoptosis of normal tissues: for example, pneumonitis following the destruction of endothelial cells in the pulmonary vasculature. Therefore, decreasing apoptosis in these tissues may reduce late effects. It may also be possible to prevent late effects such as fibrosis by blocking the induction of certain genes such as transforming growth factor beta. Cell-cycle regulation is another area that could be manipulated to increase radiosensitivity. There is evidence that the G2 delay following radiation is important in protecting cells from death. Abolition of this delay may increase radiosensitivity, especially in cells with mutant p53 that have lost the G1 checkpoint. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:639 / 653
页数:15
相关论文
共 181 条
  • [1] INCREASING THE SUSCEPTIBILITY OF THE RAT 208F FIBROBLAST CELL-LINE TO RADIATION-INDUCED APOPTOSIS DOES NOT ALTER ITS CLONOGENIC SURVIVAL DOSE - RESPONSE
    ALDRIDGE, DR
    ARENDS, MJ
    RADFORD, IR
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (03) : 571 - 577
  • [2] DNA-DAMAGE AND THE DNA-ACTIVATED PROTEIN-KINASE
    ANDERSON, CW
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1993, 18 (11) : 433 - 437
  • [3] TRANSFORMING GROWTH FACTOR-BETA-1 EXPRESSION IN IRRADIATED LIVER
    ANSCHER, MS
    CROCKER, IR
    JIRTLE, RL
    [J]. RADIATION RESEARCH, 1990, 122 (01) : 77 - 85
  • [4] CHANGES IN PLASMA TGF-BETA LEVELS DURING PULMONARY RADIOTHERAPY AS A PREDICTOR OF THE RISK OF DEVELOPING RADIATION PNEUMONITIS
    ANSCHER, MS
    MURASE, T
    PRESCOTT, DM
    MARKS, LB
    REISENBICHLER, H
    BENTEL, GC
    SPENCER, D
    SHEROUSE, G
    JIRTLE, RL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03): : 671 - 676
  • [5] TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER
    ANSCHER, MS
    PETERS, WP
    REISENBICHLER, H
    PETROS, WP
    JIRTLE, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) : 1592 - 1598
  • [6] APOPTOSIS OF VASCULAR ENDOTHELIAL-CELLS BY FIBROBLAST GROWTH-FACTOR DEPRIVATION
    ARAKI, S
    SHIMADA, Y
    KAJI, K
    HAYASHI, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) : 1194 - 1200
  • [7] BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880
  • [8] Bernhard EJ, 1996, CANCER RES, V56, P1727
  • [9] Reducing the radiation-induced G(2) delay causes HeLa cells to undergo apoptosis instead of mitotic death
    Bernhard, EJ
    Muschel, RJ
    Bakanauskas, VJ
    McKenna, WG
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1996, 69 (05) : 575 - 584
  • [10] INCREASED EXPRESSION OF CYCLIN B1 MESSENGER-RNA COINCIDES WITH DIMINISHED G(2)-PHASE ARREST IN IRRADIATED HELA-CELLS TREATED WITH STAUROSPORINE OR CAFFEINE
    BERNHARD, EJ
    MAITY, A
    MUSCHEL, RJ
    MCKENNA, WG
    [J]. RADIATION RESEARCH, 1994, 140 (03) : 393 - 400